Cetera Investment Advisers Pfizer Inc Transaction History

Cetera Investment Advisers

$42.2 Billion
Q2 2024

A detailed history of Cetera Investment Advisers transactions in Pfizer Inc stock. As of the latest transaction made, Cetera Investment Advisers holds 2,110,531 shares of PFE stock, worth $61.1 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

2,110,531

Previous 2,202,086 4.16%

Holding current value

$61.1 Million

Previous $61.1 Million 3.36%

% of portfolio

0.14%

Previous 0.15%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 22, 2024	SELL	$25.26 - $29.6 $2.31 Million - $2.71 Million	-91,555 Reduced 4.16%	2,110,531 $59.1 Million
Q1 2024 May 24, 2024	BUY	$25.89 - $29.73 $48.2 Million - $55.4 Million	1,862,290 Added 548.06%	2,202,086 $61.1 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $11.7 Million - $13.5 Million	-452,763 Reduced 57.13%	339,796 $9.43 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $2.21 Million - $2.87 Million	-84,426 Reduced 9.63%	792,559 $22.8 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $1.26 Million - $1.47 Million	39,210 Added 4.68%	876,985 $29.1 Million
Q2 2023 Aug 09, 2023	BUY	$36.12 - $41.79 $552,310 - $639,010	15,291 Added 1.86%	837,775 $30.7 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $1.33 Million - $1.74 Million	33,882 Added 4.3%	822,484 $33.6 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $6.54 Million - $8.53 Million	156,576 Added 24.77%	788,602 $40.4 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $6.5 Million - $7.94 Million	-148,543 Reduced 19.03%	632,026 $27.7 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $77,705 - $92,133	1,670 Added 0.21%	780,569 $40.9 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $1.34 Million - $1.67 Million	29,396 Added 3.92%	778,899 $40.3 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $304,073 - $450,738	7,359 Added 0.99%	749,503 $44.3 Million
Q3 2021 Nov 16, 2021	BUY	$39.25 - $50.42 $941,921 - $1.21 Million	23,998 Added 3.34%	742,144 $31.9 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $1.6 Million - $1.81 Million	44,425 Added 6.59%	718,146 $28.1 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $830,719 - $936,884	24,805 Added 3.82%	673,721 $24.4 Million
Q4 2020 Feb 17, 2021	BUY	$33.47 - $42.56 $18.2 Million - $23.1 Million	543,719 Added 516.86%	648,916 $23.9 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $180,721 - $212,027	5,692 Added 5.72%	105,197 $3.86 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $793,933 - $963,157	26,359 Added 36.04%	99,505 $3.25 Million
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $60,493 - $86,431	2,238 Added 3.16%	73,146 $2.39 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $98,430 - $111,706	2,990 Added 4.4%	70,908 $2.79 Million
Q3 2019 Nov 06, 2019	BUY	$32.49 - $42.13 $132,039 - $171,216	4,064 Added 6.36%	67,918 $2.45 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $70,927 - $79,635	1,918 Added 3.1%	63,854 $2.76 Million
Q1 2019 May 06, 2019	BUY	$37.5 - $41.2 $488,475 - $536,671	13,026 Added 26.63%	61,936 $2.62 Million
Q4 2018 Feb 15, 2019	SELL	$38.47 - $43.86 $56,666 - $64,605	-1,473 Reduced 2.92%	48,910 $2.13 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $88,450 - $107,284	2,566 Added 5.37%	50,383 $2.21 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $78,525 - $83,715	2,381 Added 5.24%	47,817 $1.74 Million
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $76,360 - $88,588	-2,393 Reduced 5.0%	45,436 $1.62 Million
Q4 2017 Feb 08, 2018	SELL	$33.26 - $35.29 $15,499 - $16,445	-466 Reduced 0.96%	47,829 $1.73 Million
Q3 2017 Nov 16, 2017	SELL	$31.0 - $34.15 $63,426 - $69,870	-2,046 Reduced 4.06%	48,295 $1.73 Million
Q2 2017 Aug 17, 2017	SELL	N/A	-57,743 Reduced 53.42%	50,341 $1.69 Million
Q2 2017 Aug 14, 2017	BUY	N/A	108,084	108,084 $3.62 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Pfizer Inc Transaction History